GSK
GSK
GSK
972 hedge funds and large institutions have $19.6B invested in GSK in 2025 Q4 according to their latest regulatory filings, with 165 funds opening new positions, 305 increasing their positions, 335 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.55% more ownership
Funds ownership: 18.96% → 19.52% (+0.55%)
9% less repeat investments, than reductions
Existing positions increased: 305 | Existing positions reduced: 335
15% less funds holding in top 10
Funds holding in top 10: 13 → 11 (-2)
Holders
972
Holding in Top 10
11
Calls
$258M
Puts
$123M
Top Buyers
| 1 | +$426M | |
| 2 | +$288M | |
| 3 | +$106M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$76.3M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$68.8M |
Top Sellers
| 1 | -$461M | |
| 2 | -$77.4M | |
| 3 | -$62.9M | |
| 4 |
CCM
Causeway Capital Management
Los Angeles,
California
|
-$53.3M |
| 5 |
Renaissance Technologies
New York
|
-$44.4M |
